[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.19.31. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editorial
July 2006

Treating Alzheimer DiseaseTime Matters

Arch Neurol. 2006;63(7):926-928. doi:10.1001/archneur.63.7.926

Alzheimer disease is a progressive and unrelenting neurodegenerative disorder causing incremental cognitive decline due to increasing neuropathologic changes including amyloid-containing neuritic plaques, aggregated hyperphosphorylated tau as neurofibrillary tangles, dystrophic neurites, gliosis, and synaptic and neuronal loss. These changes have been established findings for many years, and the impression is that they are permanent and fixed. What has emerged in recent years using transgenic mouse models containing mutant genes causal of Alzheimer disease is that these neuropathologic fixtures can indeed be altered and changed, and they have even been shown to regress.

First Page Preview View Large
First page PDF preview
First page PDF preview
×